Loading...

Mitsubishi Gas Chemical Company, Inc.

MBGCFPNK
Basic Materials
Chemicals - Specialty
$16.86
$0.00(0.00%)

Mitsubishi Gas Chemical Company, Inc. (MBGCF) Financial Performance & Income Statement Overview

Explore the financials of Mitsubishi Gas Chemical Company, Inc. (MBGCF), including yearly and quarterly data on income, cash flow, and balance sheets.

Revenue Growth
-4.90%
4.90%
Operating Income Growth
7.42%
7.42%
Net Income Growth
17.33%
17.33%
Operating Cash Flow Growth
2.68%
2.68%
Operating Margin
6.57%
6.57%
Gross Margin
21.21%
21.21%
Net Profit Margin
5.89%
5.89%
ROE
6.77%
6.77%
ROIC
6.02%
6.02%

Mitsubishi Gas Chemical Company, Inc. (MBGCF) Income Statement & Financial Overview

Review Mitsubishi Gas Chemical Company, Inc. MBGCF income statement with detailed quarterly and annual figures.

MetricQ4 2024Q3 2024Q2 2024Q1 2024
Revenue$190.40B$195.06B$200.01B$188.12B
Cost of Revenue$155.36B$155.21B$153.86B$144.87B
Gross Profit$35.04B$39.85B$46.15B$43.25B
Gross Profit Ratio$0.18$0.20$0.23$0.23
R&D Expenses$0.00$0.00$0.00$0.00
SG&A Expenses$29.48B$28.73B$27.73B$27.52B
Operating Expenses$29.48B$28.31B$28.13B$27.52B
Total Costs & Expenses$184.84B$183.52B$181.99B$172.39B
Interest Income$643.00M$449.00M$453.00M$296.00M
Interest Expense$602.00M$345.00M$541.00M$886.00M
Depreciation & Amortization$9.50B$9.16B$8.88B-$15.33B
EBITDA$15.53B$20.28B$27.30B$0.00
EBITDA Ratio$0.08$0.10$0.14$0.00
Operating Income$5.56B$11.54B$18.02B$15.73B
Operating Income Ratio$0.03$0.06$0.09$0.08
Other Income/Expenses (Net)-$1.02B$3.38B$907.00M$2.23B
Income Before Tax$4.54B$14.92B$18.93B$17.95B
Income Before Tax Ratio$0.02$0.08$0.09$0.10
Income Tax Expense-$5.65B$2.50B$4.14B$4.43B
Net Income$9.91B$10.91B$12.99B$11.73B
Net Income Ratio$0.05$0.06$0.06$0.06
EPS$50.61$54.69$64.87$58.60
Diluted EPS$50.61$54.69$64.87$58.60
Weighted Avg Shares Outstanding$195.75M$199.52M$200.26M$200.22M
Weighted Avg Shares Outstanding (Diluted)$195.75M$199.52M$200.26M$200.22M

Over the past four quarters, Mitsubishi Gas Chemical Company, Inc. demonstrated steady revenue growth, increasing from $188.12B in Q1 2024 to $190.40B in Q4 2024. Operating income reached $5.56B in Q4 2024, maintaining a consistent 3% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $15.53B, reflecting operational efficiency. Net income dropped to $9.91B, with EPS at $50.61. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;